Best Peptides Being Researched Right Now (2026)
- VPL Research Team
- Apr 1
- 15 min read
Updated: 6 days ago
Published: April 6, 2026 | Category: Peptide Research & Biohacking | Reading Time: 14 min
Disclaimer: This article is for educational and research purposes only. The peptides discussed are largely not FDA-approved for human use. This is not medical advice. Always consult a licensed healthcare provider before using any research compound.
Peptides are having a cultural moment — and for good reason. As research continues to advance across multiple fronts, these short chains of amino acids are emerging as some of the most targeted, biologically precise compounds available to the modern biohacker. From accelerating tissue repair and amplifying growth hormone production, to fighting aging at the cellular level and torching stubborn fat, the breadth of what peptides can potentially do is genuinely unlike anything seen before in wellness science.
In 2026, peptide-related searches have surpassed 10 million per month globally. Biohackers, competitive athletes, and longevity enthusiasts are searching for information on the same core question: which peptides are actually worth researching?
This guide breaks down the most actively researched peptides right now — organized by goal — with the science, real research data, and study links for every compound.
Table of Contents
BPC-157 — The Recovery King
TB-500 — Systemic Healing & Flexibility
CJC-1295 + Ipamorelin — The GH Secretagogue Stack
Retatrutide — The Triple-Agonist Weight Loss Frontier
GHK-Cu — Copper Peptide for Repair & Anti-Aging
Epithalon — The Telomere & Longevity Peptide
MOTS-c — Mitochondrial Performance Peptide
AOD-9604 — Fat Loss Without the Side Effects
Peptide Comparison Table
What to Look for When Sourcing Peptides
1. BPC-157 — Healing & Tissue Repair
Healing & Recovery-General Wellness-Fitness & Athletes-Medical / Research
Who should read this: Anyone dealing with chronic joint pain, sports injuries, slow-healing tendons, or gut issues — as well as clinicians tracking the emerging orthopedic research literature.
BPC-157 is consistently the most searched and discussed research peptide in 2026. Derived from a protein naturally found in human gastric juice, it is a 15-amino-acid synthetic peptide that has accumulated one of the largest bodies of preclinical research of any non-approved compound. Athletes call it the "Wolverine peptide." Gut health advocates use it for gastrointestinal repair. Orthopedic researchers are finally beginning to study it in clinical settings.
What the science shows
A 2025 systematic review in HSS Journal analyzed 36 studies on BPC-157 in orthopedic sports medicine published from 1993 to 2024. The findings confirmed BPC-157 enhances growth hormone receptor expression, promotes angiogenesis (new blood vessel formation), and reduces inflammatory cytokines. In preclinical models, it consistently improved structural and biomechanical outcomes across muscle tears, tendon ruptures, ligament injuries, and fractures.
The most notable human data: in a retrospective study of 12 patients with chronic knee pain, 7 of 12 reported pain relief lasting more than 6 months after a single intra-articular injection. A 2025 pilot pharmacokinetic study confirmed intravenous BPC-157 was well tolerated in healthy adults with no adverse changes in cardiac, hepatic, renal, or metabolic markers.
Beyond joints, BPC-157 is one of the few peptides with research supporting gastrointestinal healing — including inflammatory bowel conditions, gut mucosal repair, and protection against stomach lesions — which is why general wellness users frequently explore it for digestive health.
Potential benefits by audience
General wellness: Gut health, reduced systemic inflammation, faster healing from everyday injuries
Athletes: Tendon and ligament repair, faster return to training, reduced joint pain
Research professionals: Angiogenesis modulation, GH receptor upregulation, cytoprotective mechanisms
⚠️ Not FDA-approved. Human clinical data remains limited. Theoretical concern: angiogenesis promotion could theoretically accelerate precancerous cell growth. Use only under medical supervision.
📖 Vasireddi et al., HSS Journal (2025) | McGuire et al., Curr Rev Musculoskelet Med (2025) | MDPI IJMS BPC-157 Review (2026)
2. TB-500 (Thymosin Beta-4) — Systemic Recovery & Flexibility
Healing & Recovery-Fitness & Athletes-Anti-Aging & Longevity-Medical / Research
Who should read this: Athletes with recurring injuries, older adults dealing with reduced flexibility and slower recovery, and researchers studying angiogenesis and extracellular matrix biology.
Where BPC-157 tends to work locally at an injury site, TB-500 operates systemically throughout the body. Derived from thymosin beta-4 — a protein involved in actin regulation and cell migration — it is the standard "partner peptide" to BPC-157 in athletic recovery protocols. The two compounds address different mechanisms and are frequently stacked together for comprehensive healing.
What the science shows
TB-500 promotes healing through upregulation of vascular endothelial growth factor (VEGF), driving angiogenesis and significantly improving oxygen and nutrient delivery to damaged tissues. In a rat model with surgically transected medial collateral ligaments, TB-500 produced more uniform, densely organized collagen fibers and superior biomechanical strength at four weeks versus untreated controls. A 2025 review in PMC Therapeutic Peptides in Orthopaedics classified it alongside BPC-157 and GHK-Cu as a primary wound-healing peptide operating through angiogenesis, integrin-mediated ECM remodeling, and fibroblast activation.
For older adults and longevity-focused users, the systemic nature of TB-500's action — combined with its anti-inflammatory profile — makes it relevant beyond sports injuries, with theoretical benefits for age-related tissue degradation and cardiovascular repair.
Potential benefits by audience
Athletes: Faster muscle regeneration, improved joint range of motion, reduced injury recurrence
Longevity: Systemic tissue maintenance, cardiovascular tissue repair, anti-inflammatory support
Research: VEGF pathway modulation, actin polymerization research, ECM remodeling studies
⚠️ Animal studies have flagged that TB-500 may accelerate dormant tumor growth. Not FDA-approved. Research-grade only. Not for use by anyone with active or suspected malignancy.
3. CJC-1295 + Ipamorelin — Growth Hormone & Body Composition
Performance & Muscle-General Wellness-Fitness & Athletes-Anti-Aging & Longevity-Medical / Research
Who should read this: Anyone concerned about age-related GH decline, athletes seeking muscle and recovery benefits, wellness users wanting better sleep and body composition, and clinicians exploring GH secretagogue research.
After age 30, natural growth hormone production declines by roughly 14% per decade. This decline is linked to increases in body fat (especially visceral), reductions in lean muscle, poorer sleep quality, slower recovery, and reduced energy. CJC-1295 and Ipamorelin are the most extensively researched peptide pair for restoring this axis — not by introducing synthetic GH directly, but by stimulating your own pituitary gland to produce it naturally.
How they work together
CJC-1295 is a long-acting analog of growth hormone-releasing hormone (GHRH). It binds to GHRH receptors on the anterior pituitary, sustaining GH release for up to 6 days per injection. A human clinical study in the Journal of Clinical Endocrinology and Metabolism (2006) showed subcutaneous CJC-1295 produced dose-dependent increases in both GH and IGF-1 in healthy adults, with GH rising 2–10 fold above baseline.
Ipamorelin is a selective ghrelin receptor agonist (GHS-R) — consistently the most selective GHRP studied, with minimal impact on cortisol, prolactin, or ACTH. It delivers a rapid GH pulse within hours. Together, the combination exploits both GH regulatory systems simultaneously for a synergistic response that exceeds either compound alone.
Potential benefits by audience
General wellness: Improved sleep quality, better energy, enhanced skin and hair via IGF-1
Athletes: Lean muscle gain, faster recovery, improved fat metabolism
Longevity: Counteracting age-related GH decline, preserving muscle mass (sarcopenia prevention), metabolic health
Research: Pulsatile vs. sustained GH signaling models, somatotroph axis biology
⚠️ GH-axis peptides carry a theoretical cancer risk from IGF-1 elevation and cellular proliferation. Regular IGF-1 monitoring is strongly advised. Not FDA-approved.
📖 Teichman et al., J Clin Endocrinol Metab (2006) | Therapeutic Peptides in Orthopaedics — PMC (2025)
4. Retatrutide — Next-Generation Weight Loss
Weight Loss & Metabolic-General Wellness-Fitness & Athletes-Medical / Research
Who should read this: Anyone researching the most advanced weight loss peptides currently in clinical development, people who haven't responded adequately to semaglutide, and researchers tracking incretin pharmacology.
Retatrutide is the most potent weight-loss compound in clinical development today. Developed by Eli Lilly, it is a first-in-class triple-receptor agonist — simultaneously activating GLP-1, GIP, and glucagon receptors. No other approved or investigational drug matches this three-pathway approach. While Ozempic (semaglutide) hits one receptor and Mounjaro (tirzepatide) hits two, retatrutide fires all three — adding direct fat-burning through the liver and thermogenesis that the others simply cannot achieve.
24.2%
Avg loss — Phase 2, 48 wk
28.7%
Avg loss — Phase 3, 68 wk
~71 lbs
Mean lost in TRIUMPH-4
72%
Prediabetes reversal (Ph2)
What the science shows
Phase 2 data published in the New England Journal of Medicine (2023) showed 24.2% mean weight loss at 48 weeks — unprecedented at the time. The TRIUMPH-4 Phase 3 trial (December 2025) extended this to 28.7% body weight reduction at 68 weeks, alongside a 76% reduction in knee osteoarthritis pain and significant improvements in blood pressure, triglycerides, and C-reactive protein. In Phase 2, 72% of participants with prediabetes reverted to normal blood sugar.
Potential benefits by audience
General wellness: The most potent weight reduction available in any pipeline compound
Athletes: Metabolic optimization, visceral fat reduction, joint pain relief (TRIUMPH-4 data)
Research: Triple incretin agonism, glucagon receptor pharmacology, TRIUMPH trial program
⚠️ Investigational only — not FDA-approved. A new Phase 3 safety signal (dysesthesia — abnormal touch sensation) occurred in 20.9% of the highest-dose group. FDA review anticipated no earlier than 2027.
📖 Jastreboff et al., NEJM Phase 2 (2023) | Eli Lilly TRIUMPH-4 Results (Dec 2025) | Meta-analysis — PMC (2025)
5. Semaglutide (GLP-1) — The Proven Standard
Semaglutide (Ozempic / Wegovy)
Weight Loss & Metabolic-General Wellness-Fitness & Athletes-Anti-Aging & Longevity-Medical / Research
Who should read this: Anyone exploring FDA-approved weight management options, people with type 2 diabetes, those with cardiovascular disease risk factors, and anyone wanting the best-documented peptide in clinical medicine today.
No peptide on this list has more clinical validation than semaglutide. It is an FDA-approved GLP-1 receptor agonist available under multiple brand names: Ozempic (for type 2 diabetes), Wegovy (for chronic weight management), and Rybelsus (oral tablet for diabetes). With years of post-market data from millions of real-world patients, it remains the gold standard against which all newer weight loss peptides are measured.
What the science shows
The landmark STEP 1 trial enrolled 1,961 adults with obesity over 68 weeks and showed a mean weight loss of 14.9% with semaglutide 2.4 mg versus 2.4% with placebo. 86% of semaglutide participants lost at least 5% of their body weight. The SELECT cardiovascular outcomes trial further demonstrated that Wegovy reduced major adverse cardiovascular events by 20% in patients with established cardiovascular disease — a result that fundamentally changed how the medical community thinks about GLP-1 drugs.
The newer STEP UP trial (2025) evaluated semaglutide at a higher 7.2 mg investigational dose and achieved 20.7% mean weight loss — demonstrating that semaglutide still has room to grow even as newer compounds emerge.
Potential benefits by audience
General wellness: Clinically proven, FDA-approved, available now — the accessible entry point into metabolic peptide therapy
Athletes: Body recomposition support, visceral fat reduction, appetite regulation during training
Longevity: Cardiovascular risk reduction, metabolic disease prevention, blood sugar regulation
Research: The most-studied GLP-1 agonist; benchmark for all new incretin-based compounds
⚠️ Contraindicated in personal/family history of medullary thyroid carcinoma or MEN2. Gastrointestinal side effects are common during dose escalation. Requires prescription from a licensed physician.
6. GHK-Cu — Copper Peptide for Skin, Healing & Anti-Aging
Anti-Aging & Longevity-General Wellness-Fitness & Athletes-Anti-Aging & Longevity-Medical / Research
Who should read this: Anyone interested in skin health, wound healing, or cellular anti-aging — from weekend athletes using it post-training to longevity researchers studying gene expression modulation.
GHK-Cu is one of the most versatile peptides on this list. A naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine, it is unique in that it can be used both topically (in cosmetic skincare) and systemically via injection — making it relevant across multiple audiences. Critically, GHK-Cu blood levels decline significantly with age, and researchers believe this decline contributes directly to slower wound healing, increased inflammation, and visible skin aging.
What the science shows
GHK-Cu has been shown to activate over 4,000 human genes involved in healing, inflammation control, and antioxidant defense. It stimulates collagen synthesis and glycosaminoglycan production in skin cell cultures, promotes angiogenesis, and activates fibroblasts for tissue repair. A clinical study in the Journal of Drugs in Dermatology confirmed significant improvements in skin texture and reduction of aging signs. Beyond skin, a 2025 orthopedic research review placed GHK-Cu alongside BPC-157 and TB-500 as a primary tissue-healing agent operating through ECM remodeling and fibroblast activation pathways.
Potential benefits by audience
General wellness: Accessible anti-aging — available in topical form without a prescription
Athletes: Reduced inflammation, faster soft-tissue repair, collagen support for joints
Anti-aging: Skin collagen restoration, oxidative stress protection, gene expression modulation
Research: One of the broadest genomic footprints of any peptide studied
7. Epithalon — Telomeres & Cellular Longevity
Anti-Aging & Longevity-General Wellness-Anti-Aging & Longevity-Medical / Research
Who should read this: Longevity-focused individuals tracking telomere biology and cellular aging, wellness users interested in sleep optimization, and researchers studying the pineal gland, melatonin, and telomerase activation.
Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from epithalamin, a natural compound secreted by the pineal gland. It sits at the intersection of longevity science and sleep biology — and has accumulated a meaningful body of research, primarily out of Eastern Europe, suggesting it may be one of the few compounds capable of activating telomerase, the enzyme responsible for maintaining telomere length.
What the science shows
Epithalon has been shown in human cell studies to lengthen telomeres through telomerase activation — a mechanism with direct implications for cellular aging. It also normalizes circadian rhythms, regulates melatonin production from the pineal gland, and has been associated with reduced oxidative stress and improved endocrine regulation. A 2025 orthopedic peptide review noted that Epithalon's sleep and GH-promoting effects may indirectly support systemic recovery by enhancing the quality of slow-wave sleep — when the majority of natural GH is secreted.
For general wellness users, Epithalon's most accessible benefit is sleep quality improvement — particularly for people in their 40s and beyond who notice declining sleep depth and disrupted circadian rhythms.
Potential benefits by audience
General wellness: Improved deep sleep, restored circadian rhythm, antioxidant support
Anti-aging: Telomere lengthening via telomerase activation, hormonal regulation, cellular age reversal research
Research: Pineal biology, telomerase pharmacology, circadian endocrinology
⚠️ Most human data comes from small Eastern European trials. Not FDA-approved. Long-term safety profile in large populations is not established.
8. MOTS-c — Mitochondrial Energy & Metabolism
Performance & Metabolic-General Wellness-Fitness & Athletes-Anti-Aging & Longevity-Medical / Research
Who should read this: Anyone experiencing age-related metabolic slowdown, athletes wanting genuine endurance gains, people managing insulin resistance, and researchers exploring mitochondrial medicine.
MOTS-c is genuinely unlike any other peptide on this list. It is encoded not by nuclear DNA, but by mitochondrial DNA — making it a mitochondrial-derived peptide (MDP) that acts as a metabolic signal from your cells' energy centers to the rest of the body. MOTS-c levels decline with age and are lower in individuals with metabolic syndrome and type 2 diabetes, suggesting that its decline may be a direct contributor to age-related metabolic deterioration.
What the science shows
MOTS-c activates the AMPK pathway — a central metabolic sensor governing energy expenditure, fat oxidation, and glucose uptake. In animal models, MOTS-c administration improved physical endurance beyond what training alone could produce, improved insulin sensitivity, and reduced age-related metabolic dysfunction. It is currently being studied as a preventive agent for type 2 diabetes, metabolic syndrome, and age-related physical decline.
For the general wellness reader: MOTS-c is what happens when your mitochondria are functioning optimally — better energy, better fat use, better blood sugar stability. Declining MOTS-c is one of the reasons metabolism feels "broken" as we age.
Potential benefits by audience
General wellness: Metabolic reset, improved energy levels, blood sugar stability
Athletes: Enhanced endurance, faster fat oxidation, improved VO2 efficiency
Anti-aging: Counteracting age-related mitochondrial decline, metabolic disease prevention
Research: AMPK activation, mitochondrial biology, mitokine pharmacology
⚠️ Early-stage research — most data is preclinical or from small human trials. Established dosing protocols for humans do not yet exist.
9. AOD-9604 — Targeted Fat Loss
Weight Loss & Fat Burning-General Wellness-Fitness & Athletes-Medical / Research
Who should read this: People who want fat loss without hormonal disruption, athletes in cutting phases who need to preserve joint health, and anyone frustrated by stubborn fat that doesn't respond to diet and exercise alone.
AOD-9604 is a modified fragment of human growth hormone — specifically the C-terminal region (amino acids 176–191) responsible for fat metabolism — engineered to trigger lipolysis without activating the insulin-disrupting or growth-promoting effects of full GH. This makes it arguably the cleanest targeted fat-burning peptide available, with minimal downstream hormonal consequences.
What the science shows
An Australian clinical study of 300 obese participants over 12 weeks found that the 1 mg daily AOD-9604 group lost an average of 2.8 kg — more than three times the placebo group — without significant changes in blood sugar, cholesterol, or other metabolic markers. This level of fat loss exceeded that of the leading prescription obesity drug in comparable trials at the time. Additional research suggests AOD-9604 may support cartilage regeneration, making it particularly valuable during caloric deficits when joint stress is high and recovery capacity is reduced.
Potential benefits by audience
General wellness: Accessible fat loss support without appetite suppression side effects
Athletes: Preserving muscle while losing fat; joint support during cutting phases
Research: GH fragment pharmacology, lipolytic signaling without full GH axis activation
10. Thymosin Alpha-1 — Immune Support & Resilience
Immune & Recovery-General Wellness-Anti-Aging & Longevity-Medical / Research
Who should read this: Anyone focused on immune resilience, people recovering from illness or overtraining, older adults concerned about immune senescence, and researchers studying T-cell biology and immunomodulation.
Thymosin Alpha-1 is one of the few peptides on this list with a legitimate clinical track record in humans — it is approved in over 35 countries (though not the US) for treating hepatitis B, hepatitis C, and certain cancers, and is used in intensive care settings for sepsis management. In wellness and longevity circles, it is gaining attention for its ability to enhance immune surveillance and T-cell activity at a time when immune system function declines with age.
What the science shows
Thymosin Alpha-1 activates T-cells — the immune system's front-line defense — and has been shown to enhance both innate and adaptive immunity. It upregulates toll-like receptors, increases natural killer (NK) cell activity, and promotes dendritic cell maturation. Research has demonstrated antiviral, antibacterial, and anti-tumor activity in clinical populations. For longevity users, the relevance is immunosenescence — the natural decline of immune function with age that leaves older adults more vulnerable to infections, autoimmunity, and cancer. Thymosin Alpha-1 is one of the most studied peptides for restoring immune vigor in aging populations.
The February 2026 HHS reclassification announcement included Thymosin Alpha-1 among the peptides expected to return to compounding availability in the US — a significant shift that makes it more accessible to American patients and practitioners.
Potential benefits by audience
General wellness: Immune resilience, reduced illness frequency, faster recovery from infections
Anti-aging: Reversal of immunosenescence, enhanced immune surveillance against abnormal cells
Research: Approved in 35+ countries; one of the most clinically validated immunomodulatory peptides
11. Quick-Reference Comparison Table
Peptide | Primary Goal | Best For | Research Stage | FDA Status |
BPC-157 | Tissue repair, gut healing | Athletes, wellness | Preclinical + early human | Not approved |
TB-500 | Systemic healing, flexibility | Athletes, longevity | Preclinical + animal | Not approved |
CJC-1295 / Ipamorelin | GH, muscle, fat, sleep | All audiences | Human clinical data | Not approved |
Retatrutide | Weight loss, metabolic health | Wellness, research | Phase 3 trials | Investigational |
Semaglutide | Weight loss, diabetes, cardio | All audiences | Fully approved | ✅ FDA Approved |
GHK-Cu | Skin, anti-aging, repair | All audiences | Preclinical + cosmetic human | Topical only (OTC) |
Epithalon | Longevity, sleep, telomeres | Wellness, longevity | Early human (Eastern Europe) | Not approved |
MOTS-c | Mitochondria, endurance, metabolism | All audiences | Preclinical + small human | Not approved |
AOD-9604 | Fat loss, cartilage support | Wellness, athletes | Phase 2 human trials | Not approved |
Thymosin Alpha-1 | Immune support, resilience | Wellness, longevity | Approved internationally | Not approved (US) |
12. How to Source Peptides Safely
With over $328 million in gray-market peptide imports entering the US in 2025 alone, the quality gap between suppliers has never been more important. Poor-quality peptides may contain contaminants, incorrect concentrations, or impurities that carry real health risks. Here is what every buyer — regardless of background — should verify before purchasing any research peptide:
Certificate of Analysis (CoA) from a third-party lab: Every batch should have an independent lab report confirming purity (ideally >98%), identity, and absence of harmful contaminants. This is non-negotiable.
HPLC and Mass Spectrometry testing: These are the gold standards for peptide identity and purity verification. If a supplier doesn't offer these, look elsewhere.
Sterile lyophilized (freeze-dried) powder: Peptides should come as sterile, lyophilized powder — not pre-mixed solutions, which have shorter shelf lives and higher contamination risk.
US-based manufacturing or verified GMP facilities: Domestically produced or GMP-certified peptides are subject to better oversight than unverified offshore manufacturing.
Transparent sourcing and company information: Reputable suppliers clearly communicate where and how their peptides are synthesized and will answer questions directly.
On the regulatory front, the February 2026 announcement from HHS signaled that approximately 14 previously restricted peptides — including BPC-157, GHK-Cu, Thymosin Alpha-1, CJC-1295, Ipamorelin, and AOD-9604 — may return to Category 1 status. If finalized, this means licensed US compounding pharmacies could once again legally prepare these peptides with a physician's prescription — a major shift in legitimate access for American users.
🔬 Looking for research-grade peptides with verified CoA documentation? Browse our full catalog and stay ahead of the science. → Shop Peptides
Final Thoughts
The peptide landscape in 2026 offers something genuinely meaningful for every type of health-conscious person. For the weekend warrior with a nagging tendon, BPC-157 and TB-500 are at the frontier of recovery science. For anyone carrying excess weight, semaglutide is proven and available today, while retatrutide represents what the next chapter may look like. For those thinking about the long game — staying strong, sharp, and metabolically healthy into their 60s, 70s, and beyond — CJC-1295/Ipamorelin, Epithalon, MOTS-c, GHK-Cu, and Thymosin Alpha-1 collectively address the most critical biological levers of aging.
The science is advancing faster than at any point in history. The most important things to carry forward: stay informed, work with a knowledgeable medical provider, monitor your biomarkers, and source only from suppliers who can prove what they're selling. The rewards of getting this right — faster healing, better body composition, more energy, and a longer healthspan — are real. The risks of getting it wrong are equally real.
Key Study References
1. Vasireddi N et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine. HSS Journal. 2025. https://pubmed.ncbi.nlm.nih.gov/40756949/
2. McGuire FP et al. Regeneration or Risk? BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12446177/
3. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. PMC. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12753158/
4. Teichman SL et al. Prolonged Stimulation of GH and IGF-1 by CJC-1295. J Clin Endocrinol Metab. 2006. https://pubmed.ncbi.nlm.nih.gov/16352683/
5. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM. 2021. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
6. Jastreboff AM et al. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — Phase 2 Trial. NEJM. 2023. https://www.nejm.org/doi/full/10.1056/NEJMoa2301972
7. Eli Lilly TRIUMPH-4 Phase 3 Topline Results. December 2025. https://investor.lilly.com/news-releases/...
8. STEP UP Trial — Semaglutide 7.2 mg Results. Applied Clinical Trials. 2025. https://www.appliedclinicaltrialsonline.com/view/step-up-trial-semaglutide-superior-weight-loss
9. From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair. MDPI IJMS. 2026. https://www.mdpi.com/1422-0067/27/6/2876
10. Retatrutide Meta-analysis — Efficacy and Safety. Baylor University Medical Center / PMC. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12026077/
Tags: peptides 2026 · BPC-157 · TB-500 · CJC-1295 · ipamorelin · retatrutide · semaglutide · GHK-Cu · epithalon · MOTS-c · AOD-9604 · thymosin alpha-1 · peptide research · biohacking · anti-aging · weight loss peptides · fitness recovery · longevity · general wellness · growth hormone peptides
